Next Article in Journal
In Vitro Effects of Lemon Balm Extracts in Reducing the Growth and Mycotoxins Biosynthesis of Fusarium culmorum and F. proliferatum
Next Article in Special Issue
Does Deoxynivalenol Affect Amoxicillin and Doxycycline Absorption in the Gastrointestinal Tract? Ex Vivo Study on Swine Jejunum Mucosa Explants
Previous Article in Journal
Occurrence, Serotypes and Virulence Characteristics of Shiga-Toxin-Producing Escherichia coli Isolates from Goats on Communal Rangeland in South Africa
Previous Article in Special Issue
Practical Application of Urinary Zearalenone Monitoring System for Feed Hygiene Management of a Japanese Black Cattle Breeding Herd—The Relationship between Monthly Anti-Müllerian Hormone and Serum Amyloid A Concentrations
 
 
Article
Peer-Review Record

Carry-Over of Zearalenone and Its Metabolites to Intestinal Tissues and the Expression of CYP1A1 and GSTπ1 in the Colon of Gilts before Puberty

by Magdalena Mróz 1, Magdalena Gajęcka 1,*, Paweł Brzuzan 2, Sylwia Lisieska-Żołnierczyk 3, Dawid Leski 4, Łukasz Zielonka 1 and Maciej T. Gajęcki 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Submission received: 20 April 2022 / Revised: 14 May 2022 / Accepted: 17 May 2022 / Published: 18 May 2022
(This article belongs to the Special Issue Influence of Deoxynivalenol and Zearalenone in Feed on Animal Health)

Round 1

Reviewer 1 Report

Summary and general appreciation:

This study aimed to determine whether low doses of zearalenone (ZEN) influence 5 the carry-over of ZEN and its metabolites to intestinal tissues and the expression of CYP1A1 and 6 GSTπ1 in the large intestine. I think the is well written and structured and I think it is very important for the scientific community and falls within the scope of this journal.

My major concern relies in fact that no any validation results were presented for ZEN determination in tissues or feed.  The authors refer the validation methodologies, but do not mention any validation data. I think the manuscript should be accepted if these results are to be provided, at least as supplementary material.

Minor comments:

Abstract/Key contribution

I don’t think the key contribution is evident enough in the abstract.

Author Response

This study aimed to determine whether low doses of zearalenone (ZEN) influence 5 the carry-over of ZEN and its metabolites to intestinal tissues and the expression of CYP1A1 and 6 GSTπ1 in the large intestine. I think the is well written and structured and I think it is very important for the scientific community and falls within the scope of this journal.

My major concern relies in fact that no any validation results were presented for ZEN determination in tissues or feed.  The authors refer the validation methodologies, but do not mention any validation data. I think the manuscript should be accepted if these results are to be provided, at least as supplementary material.

Responding to the Reviewer's comments

  • Thank you for your favorable review. At the same time, in response to the presented remark, we have introduced appropriate additions to the text (in red). For the validation of mycotoxins in feed, we submitted the validation data in the form of supplementary material (Table S1);

Minor comments:

Abstract/Key contribution

I don’t think the key contribution is evident enough in the abstract

  • Abstract / Key contribution - we changed the content by introducing bolder and expressive statements that motivate our scientific activity

Author Response File: Author Response.docx

Reviewer 2 Report

Dear authors,

Congratulations on this excellent study and well written article based on an in vivo experiment with many results. The aim of this study was to determine whether low doses of zearalenone (ZEN) influence the carry-over of ZEN and its metabolites to intestinal tissues and the expression of CYP1A1 and GSTπ1 in the large intestine. My comments:
- In such an experiment, why do not you analyze the feed for other mycotoxins, e.g., using the multimycotoxin method, to ensure that you are only studying the effects of ZEN?
- Table 1: SD is very large in some cases, e.g. 33.13±48.53

Author Response

Congratulations on this excellent study and well written article based on an in vivo experiment with many results. The aim of this study was to determine whether low doses of zearalenone (ZEN) influence the carry-over of ZEN and its metabolites to intestinal tissues and the expression of CYP1A1 and GSTπ1 in the large intestine.

Thank you for your favorable review.

My comments:

  • In such an experiment, why do not you analyze the feed for other mycotoxins, e.g., using the multimycotoxin method, to ensure that you are only studying the effects of ZEN?

  • Little is known about the interactions of low doses with the macroorganism or other mycotoxins. As well as the knowledge at the level proposed by us is not very big. Therefore, we proposed a model of the experiment that is more unambiguous with the smallest possible number of factors introducing uncertainty.

 

  • Table 1: SD is very large in some cases, e.g. 33.13±48.53

 

  • This is not the only example where SD values are greater than mean concentration. This proves that the course of metabolic processes in pre-pubertal gilts is highly individual. Hence the averaging of the results for at least five animals in the experiment.

Author Response File: Author Response.docx

Back to TopTop